These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 23996720)

  • 21. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
    Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
    JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy.
    Chine VB; Au NPB; Kumar G; Ma CHE
    Mol Neurobiol; 2019 May; 56(5):3244-3259. PubMed ID: 30117103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives.
    Poupon L; Kerckhove N; Vein J; Lamoine S; Authier N; Busserolles J; Balayssac D
    Expert Opin Drug Saf; 2015 Aug; 14(8):1269-82. PubMed ID: 26058312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Updating your peripheral neuropathy "know-how".
    Marrs J; Newton S
    Clin J Oncol Nurs; 2003; 7(3):299-303. PubMed ID: 12793336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Therapeutic Potential of Chemokines in the Treatment of Chemotherapy- Induced Peripheral Neuropathy.
    Zhou L; Ao L; Yan Y; Li W; Ye A; Hu Y; Fang W; Li Y
    Curr Drug Targets; 2020; 21(3):288-301. PubMed ID: 31490748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy.
    Molassiotis A; Cheng HL; Leung KT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; Ng TR; Suen LKP; Chan CW; Yorke J; Lopez V
    Brain Behav; 2019 Jun; 9(6):e01312. PubMed ID: 31063261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy.
    Mizrahi D; Park SB; Li T; Timmins HC; Trinh T; Au K; Battaglini E; Wyld D; Henderson RD; Grimison P; Ke H; Geelan-Small P; Marker J; Wall B; Goldstein D
    JAMA Netw Open; 2021 Feb; 4(2):e2036695. PubMed ID: 33587134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test.
    McCrary JM; Goldstein D; Wyld D; Henderson R; Lewis CR; Park SB
    J Cancer Surviv; 2019 Aug; 13(4):495-502. PubMed ID: 31172429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy.
    Lees JG; Makker PG; Tonkin RS; Abdulla M; Park SB; Goldstein D; Moalem-Taylor G
    Eur J Cancer; 2017 Mar; 73():22-29. PubMed ID: 28104535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: a qualitative thematic synthesis.
    Tanay MAL; Armes J; Ream E
    Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 26786536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage Toll-like Receptor 9 Contributes to Chemotherapy-Induced Neuropathic Pain in Male Mice.
    Luo X; Huh Y; Bang S; He Q; Zhang L; Matsuda M; Ji RR
    J Neurosci; 2019 Aug; 39(35):6848-6864. PubMed ID: 31270160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer.
    Kandula T; Farrar MA; Kiernan MC; Krishnan AV; Goldstein D; Horvath L; Grimison P; Boyle F; Baron-Hay S; Park SB
    Clin Neurophysiol; 2017 Jul; 128(7):1166-1175. PubMed ID: 28511129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol.
    Jang CE; Jung MS; Sohn EH; Kim M; Yoo HS; Bae K; Kim JR; Lee JS
    Trials; 2018 Sep; 19(1):526. PubMed ID: 30268158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chemotherapy-induced peripheral neuropathy; impact on quality of life].
    Scheel A; Beijers AJ; Mols F; Faber CG; Vreugdenhil G
    Ned Tijdschr Geneeskd; 2014; 158():A7455. PubMed ID: 25315326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview.
    Chan A; Hertz DL; Morales M; Adams EJ; Gordon S; Tan CJ; Staff NP; Kamath J; Oh J; Shinde S; Pon D; Dixit N; D'Olimpio J; Dumitrescu C; Gobbo M; Kober K; Mayo S; Pang L; Subbiah I; Beutler AS; Peters KB; Loprinzi C; Lustberg MB
    Support Care Cancer; 2019 Oct; 27(10):3729-3737. PubMed ID: 31363906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Structural Equation Approach With the Theory of Unpleasant Symptoms.
    Kim M; Jung MS
    Cancer Nurs; 2021 Mar-Apr 01; 44(2):145-153. PubMed ID: 31833921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy-induced peripheral neuropathy in the adult.
    Saad M; Tafani C; Psimaras D; Ricard D
    Curr Opin Oncol; 2014 Nov; 26(6):634-41. PubMed ID: 25229554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.
    Schloss J; Colosimo M; Vitetta L
    Crit Rev Food Sci Nutr; 2017 Apr; 57(6):1107-1118. PubMed ID: 25849070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Animal models of chemotherapy-evoked painful peripheral neuropathies.
    Authier N; Balayssac D; Marchand F; Ling B; Zangarelli A; Descoeur J; Coudore F; Bourinet E; Eschalier A
    Neurotherapeutics; 2009 Oct; 6(4):620-9. PubMed ID: 19789067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
    Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
    Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.